Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
Blood (2010) 115 (25): 5137–5146.
Currently there are no citedby results. Try again later.
